{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-068927","form_type":"8-K","ticker":"ALKS","cik":"0001520262","company_name":"Alkermes plc.","filed_at":"2026-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.308566+00:00","generated_at":"2026-05-16T00:15:49.553809+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Alkermes CEO Richard Pops to retire July 31, 2026; COO Blair Jackson named successor","bullets":["Richard Pops retires as CEO effective July 31, 2026, after 35-year tenure; will remain Chairman and Senior Advisor through Dec 31, 2026.","Blair Jackson, current EVP/COO, appointed CEO effective Aug 1, 2026; Jackson has over 25 years experience at Alkermes.","Pops receives $75k/month advisory retainer, pro-rated FY2026 bonus at target, $2.69M RSU grant vesting Dec 31, 2026, and $40k Chairman retainer.","Outstanding equity awards continue vesting post-retirement; post-termination exercise periods extended up to 21 months.","Company cites ~$1.5B annual revenue, ~2,000 employees, and alixorexton's Breakthrough Therapy designation for narcolepsy type 1."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-068927","json":"https://secwatch.observer/filing/0001193125-26-068927.json","markdown":"https://secwatch.observer/filing/0001193125-26-068927.md","text":"https://secwatch.observer/filing/0001193125-26-068927.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1520262/000119312526068927/0001193125-26-068927-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1520262/000119312526068927/alks-20260224.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T00:15:49.553809+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}